Table 3 Trend of liver fibrosis indices in two years follow-up.

From: Impact of bariatric surgery on liver fibrosis indices among type 2 diabetes patients in a national cohort

 

Pre-operative

(N = 1205)

3-months visit (N = 1205)

6-months visit (N = 947)

One-year visit (N = 588)

Two-year visit (N = 263)

SG

OAGB/MGB

RYGB

Total

SG

OAGB/MGB

RYGB

Total

SG

OAGB/MGB

RYGB

Total

SG

OAGB/MGB

RYGB

Total

SG

OAGB/MGB

RYGB

Total

FIB-4

0.87 (0.61)

0.82 (0.37)

0.83 (0.65)

0.83 (0.50)

0.93 (0.56)

0.96 (0.46)

0.90 (0.51)

0.94 (0.48)

0.88 (0.46)

0.94 (0.60)

0.88 (0.55)

0.91 (0.57)

0.93 (0.45)

0.95 (0.44)

0.94 (0.65)

0.94 (0.51)

0.97 (0.43)

1.00 (0.43)

1.06 (0.72)

1.01 (0.53)

NFS

− 0.19 (1.50)

− 0.22 (1.28)

− 0.61 (1.27)

− 0.32 (1.32) *

− 0.53 (1.42)

− 0.61 (1.90)

− 1.08 (1.94)

− 0.72 (1.86) *

− 0.73 (1.32)

− 0.74 (1.41)

− 1.16 (1.19)

− 0.83 (1.36) *

− 0.68 (1.30)

− 0.94 (1.11)

− 1.08 (1.23)

− 0.93 (1.17)

− 0.44 (1.36)

− 0.92 (1.12)

− 0.88 (1.13)

− 0.86 (1.15)

APRI

0.28 (0.22)

0.26 (0.19)

0.27 (0.23)

0.27 (0.20)

0.26 (0.16)

0.27 (0.15)

0.24 (0.13)

0.26 (0.15) *

0.21 (0.11)

0.22 (0.14)

0.21 (0.12)

0.21 (0.13)

0.20 (0.08)

0.23 (0.11)

0.23 (0.14)

0.23 (0.12)

0.22 (0.11)

0.24 (0.11)

0.26 (0.19)

0.25 (0.14)

  1. Data are presented as mean (SD).
  2. OAGB/MGB: one anastomosis gastric bypass/mini gastric bypass; SG: sleeve gastrectomy; RYGB: Roux-en-Y gastric bypass; BMI: body mass index; FIB-4: Fibrosis-4; NFS: NAFLD Fibrosis Score; APRI: aspartate aminotransferase to Platelet Ratio; *P- values < 0.05 between groups.